Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Expiring Stock Options

<< Previous

Bullboard Posts

Next >>

Comment by SABBOBCATon Jan 03, 2023 10:26pm

144 Views

Post# 35201976

RE:RE:Expiring Stock Options

SEDI is where you can find that info.

Also, as for the Dec 2022 expiry, I got it straight from IR that they have extended to 10 days post blackout period.

Wino115 wrote: It may be in the annual proxy statements. There is also the ability to adjust expiry dates if conditions warrant it and Board approves. We'll only find out later if that's what happened to the year end ones or if they just exercised them and tucked them away.

PWIB123 wrote: Where are you all tracking the options granted that are expiring specific to the insiders? I see the options granted in the financial reports and the breakdown of the number of options owned by each director/executive officer in the annual report, but I don't see anything regarding option expiration dates.